CME vs SPGI
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
CME · CME Group$305.89 ▼ 0.44%
SPGI · S&P Global$467.80 ▼ 0.98%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- CME +14.6%
- SPGI +1.0%
Head to head
| Metric | CME | SPGI |
|---|---|---|
| Price | $305.89 | $467.80 |
| Change today | ▼ 0.44% | ▼ 0.98% |
| Market cap | $109.49B | $135.62B |
| Return, 3 months | +16.6% | +14.1% |
| Return, year to date | +15.8% | -4.7% |
| Return, 1 year | +14.9% | +0.5% |
| P/E (TTM) | 25.1 | 27.8 |
| P/B | 4.1 | 6.9 |
| P/E percentile vs own 5y | 47th | 19th |
| Dividend yield | 3.69% | 0.83% |
| Revenue growth (YoY, latest qtr) | +13.0% | +6.8% |
| Net profit growth (YoY) | +14.2% | +6.6% |
| Gross margin | 86.6% | 71.0% |
| Operating margin | 65.7% | 42.8% |
| Net margin | 63.1% | 30.6% |
| Return on equity | 16.1% | 18.9% |
| Analyst target vs. price | +2.5% | +13.6% |
| Analyst buy share | 55% | 100% |
| RSI (14) | 64 | 65 |
| 30-day volatility | 24.2% | 24.6% |
| Max drawdown, 1 year | -31.1% | -28.5% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SPGI is the largest of the group by market value.
- CME has returned the most over the past year.
- CME carries the lowest trailing P/E.
- CME pays the highest dividend yield.
- CME is growing revenue fastest.
- CME keeps the most profit per dollar of sales.
- CME has been the calmest stock over the last 30 days.